Insulin-Like Growth Factor 2 mRNA Binding Protein 1 (IGF2BP1) (Internal Region) Peptide
IGF2BP1
Reactivité: Humain
Hôte: Synthetic
BP, BI
-
- Antigène Tous les produits IGF2BP1
- IGF2BP1 (Insulin-Like Growth Factor 2 mRNA Binding Protein 1 (IGF2BP1))
- Type de proteíne
- Synthetic
- Protein Region
- Internal Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Attributs du produit
- IGF2BP1 peptide is a synthetic peptide corresponding to the Internal region of IMP1.
-
-
- Indications d'application
- IGF2BP1 Peptide is used for blocking the activity of IGF2BP1 antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- IGF2BP1 peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 ?L water, the concentration will be 0.5 mg/mL.
- Conseil sur la manipulation
- When reconstituted minimize freezing and thawing.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20 °C.
-
- Antigène
- IGF2BP1 (Insulin-Like Growth Factor 2 mRNA Binding Protein 1 (IGF2BP1))
- Synonymes
- IGF2BP1 Peptide, ZBP1 Peptide, CRD-BP Peptide, CRDBP Peptide, IMP-1 Peptide, IMP1 Peptide, VICKZ1 Peptide, AL024068 Peptide, AW549074 Peptide, Crdbp Peptide, D030026A21Rik Peptide, D11Moh40e Peptide, D11Moh45 Peptide, Neilsen Peptide, Zbp1 Peptide, Imp1 Peptide, wu:fi72a06 Peptide, zgc:152963 Peptide, insulin like growth factor 2 mRNA binding protein 1 Peptide, insulin-like growth factor 2 mRNA binding protein 1 Peptide, IGF2BP1 Peptide, Igf2bp1 Peptide, igf2bp1 Peptide
- ID gène
- 10642
- NCBI Accession
- NP_005682, NP_064693
- UniProt
- Q9NZI8
-
Vous êtes ici:
